Up to half of participants in the two trials of the experimental drug ended up with only mild sleep apnea, per the post.
Recap by typeshit. Post by @science__sphere on Instagram.
A physio fielding years of peptide questions says strong studies are lacking, while noting that a lack of evidence doesn't prove they fail.
Nippard puts the two approved drugs on top for supervised weight loss and holds retatrutide at B-tier until it is approved.
Bloomberg traces how Amgen used genetic data from Iceland to guide its obesity drug research.
Researchers in Denmark report pancreatic cells that naturally produce GLP-1, the hormone drugs like semaglutide are built to mimic.
Health minister Dzulkefly says the government did not set aside dedicated 2026 budget funds for the two GLP-1 treatments.
The unapproved Lilly drug was confiscated in a dozen enforcement raids, part of a growing crackdown on gray-market retatrutide sellers.
Loading…